Episode 94: Is Adding a Diagnoses to a Medicare Advantage Patient FWA or a Positive Step in Social Determinants of Health (SDOH)

Episode 38: Interviewing & the Importance of Consistency

OIG Roundtable (Formerly Retro Fraud) Episode 38: Interviewing & the Importance of Consistency Play Episode Pause Episode Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30 seconds 00:00 / 23:57 Subscribe Share Spotify RSS Feed Share Link Embed Download file...
Is Ozempic the new Solaraze?

Is Ozempic the new Solaraze?

For those that remember Solaraze, it is one of the name brands for Diclofenac.  Diclofenac is commonly known today as Voltaren.  In 2018, the OIG conducted a study that reflected that there were some strong fraud indicators on the off-label use of Diclofenac (under...
Episode 94: Is Adding a Diagnoses to a Medicare Advantage Patient FWA or a Positive Step in Social Determinants of Health (SDOH)

Episode 31: Challenges of Managing an SIU

OIG Roundtable (Formerly Retro Fraud) Episode 31: Challenges of Managing an SIU Play Episode Pause Episode Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30 seconds 00:00 / 33:20 Subscribe Share Spotify RSS Feed Share Link Embed Download file | Play in new...